title: E phage gene transfection associated to chemotherapeutic agents increases apoptosis in lung and colon cancer cells.
abstract: The limited ability of conventional therapies to achieve the long-term survival of metastatic lung and colon cancer patients suggests the need for new treatment options. In this respect, genes encoding cytotoxic proteins have been proposed as a new strategy to enhance the activity of drugs, and combined therapies involving such genes and classical antitumoral drugs have been studied intensively. The E gene from phiX174 encodes a membrane protein with a toxic domain that leads to a decrease in tumour cell growth rates. Therefore, in order to improve the anti-tumour effects of currently used chemotherapeutic drugs on cancer cells, we investigated the association of the E suicide gene with these antineoplastic drugs. The E gene has antitumoral effects in both lung and colon cancer cells. In addition, expression of this gene induces ultrastructural changes in lung cancer transfected cells (A-549), although the significance of these changes remains unknown. The effect of combined therapy (gene and cytotoxic therapy) enhances the inhibition of tumour cell proliferation in comparison to single treatments. Indeed, our in vitro results indicate that an experimental therapeutic strategy based on this combination of E gene therapy and cytotoxic drugs may result in a new treatment strategy for patients with advanced lung and colon cancer.
authors: Department of Health Science, University of Jaen, Jaen, Spain.
authors: Ana R
authors: AR
authors: Rama
authors: Jose
authors: J
authors: Prados
authors: Consolacion
authors: C
authors: Melguizo
authors: Pablo J
authors: PJ
authors: Alvarez
authors: Raúl
authors: R
authors: Ortiz
authors: Roberto
authors: R
authors: Madeddu
authors: Antonia
authors: A
authors: Aranega
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D001435:Bacteriophages / Q000235:genetics* / Q000378:metabolism; D001691:Biological Therapy; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005822:Genetic Vectors / Q000235:genetics / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism / Q000633:toxicity*
chemical_list: D000970:Antineoplastic Agents; C029555:E protein, bacteriophage X174; D014764:Viral Proteins